190 related articles for article (PubMed ID: 16487597)
1. Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study.
Klipstein KG; Goldberg JF
J Affect Disord; 2006 Apr; 91(2-3):205-9. PubMed ID: 16487597
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome in women using valproate: a review.
Bilo L; Meo R
Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
[TBL] [Abstract][Full Text] [Related]
3. Reliability of the Mood Disorder Questionnaire: comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sample.
Dodd S; Williams LJ; Jacka FN; Pasco JA; Bjerkeset O; Berk M
Aust N Z J Psychiatry; 2009 Jun; 43(6):526-30. PubMed ID: 19440884
[TBL] [Abstract][Full Text] [Related]
4. Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode.
Tafalla M; Sanchez-Moreno J; Diez T; Vieta E
J Affect Disord; 2009 Apr; 114(1-3):299-304. PubMed ID: 18701169
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
Joffe H; Cohen LS; Suppes T; Hwang CH; Molay F; Adams JM; Sachs GS; Hall JE
Biol Psychiatry; 2006 Dec; 60(12):1378-81. PubMed ID: 16950230
[TBL] [Abstract][Full Text] [Related]
6. Screening for bipolar disorders using a French version of the Mood Disorder Questionnaire (MDQ).
Weber Rouget B; Gervasoni N; Dubuis V; Gex-Fabry M; Bondolfi G; Aubry JM
J Affect Disord; 2005 Sep; 88(1):103-8. PubMed ID: 16054228
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
[TBL] [Abstract][Full Text] [Related]
8. Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse.
Goldberg JF; Garakani A; Ackerman SH
J Clin Psychiatry; 2012 Dec; 73(12):1525-30. PubMed ID: 23290325
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders.
Ettinger AB; Reed ML; Goldberg JF; Hirschfeld RM
Neurology; 2005 Aug; 65(4):535-40. PubMed ID: 16116112
[TBL] [Abstract][Full Text] [Related]
10. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32).
Vieta E; Sánchez-Moreno J; Bulbena A; Chamorro L; Ramos JL; Artal J; Pérez F; Oliveras MA; Valle J; Lahuerta J; Angst J;
J Affect Disord; 2007 Aug; 101(1-3):43-55. PubMed ID: 17189651
[TBL] [Abstract][Full Text] [Related]
11. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
12. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
Joffe H; Cohen LS; Suppes T; McLaughlin WL; Lavori P; Adams JM; Hwang CH; Hall JE; Sachs GS
Biol Psychiatry; 2006 Jun; 59(11):1078-86. PubMed ID: 16448626
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of the Mood Disorder Questionnaire as a screening tool for bipolar disorder during pregnancy and the postpartum period.
Frey BN; Simpson W; Wright L; Steiner M
J Clin Psychiatry; 2012 Nov; 73(11):1456-61. PubMed ID: 23146292
[TBL] [Abstract][Full Text] [Related]
14. Epilepsy and polycystic ovary syndrome: where is the link?
Bilo L; Meo R
Neurol Sci; 2006 Sep; 27(4):221-30. PubMed ID: 16998724
[TBL] [Abstract][Full Text] [Related]
15. Screening for bipolar disorder: the utility and comparative properties of the MSS and MDQ measures.
Parker G; Fletcher K; Barrett M; Synnott H; Breakspear M; Hyett M; Hadzi-Pavlovic D
J Affect Disord; 2008 Jul; 109(1-2):83-9. PubMed ID: 18082895
[TBL] [Abstract][Full Text] [Related]
16. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.
O'Donovan C; Kusumakar V; Graves GR; Bird DC
J Clin Psychiatry; 2002 Apr; 63(4):322-30. PubMed ID: 12000206
[TBL] [Abstract][Full Text] [Related]
17. Bipolarity in depressive patients without histories of diagnosis of bipolar disorder and the use of the Mood Disorder Questionnaire for detecting bipolarity.
Kim B; Wang HR; Son JI; Kim CY; Joo YH
Compr Psychiatry; 2008; 49(5):469-75. PubMed ID: 18702932
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of the mood disorder questionnaire and the bipolar spectrum diagnostic scale in Argentinean patients with mood disorders.
Zaratiegui RM; Vázquez GH; Lorenzo LS; Marinelli M; Aguayo S; Strejilevich SA; Padilla E; Goldchluk A; Herbst L; Vilapriño JJ; Bonetto GG; Cetkovich-Bakmas MG; Abraham E; Kahn C; Whitham EA; Holtzman NS; Ghaemi N
J Affect Disord; 2011 Aug; 132(3):445-9. PubMed ID: 21440943
[TBL] [Abstract][Full Text] [Related]
19. Genetic overlap between polycystic ovary syndrome and bipolar disorder: the endophenotype hypothesis.
Jiang B; Kenna HA; Rasgon NL
Med Hypotheses; 2009 Dec; 73(6):996-1004. PubMed ID: 19556071
[TBL] [Abstract][Full Text] [Related]
20. Women with polycystic ovary syndrome are often depressed or anxious--a case control study.
Månsson M; Holte J; Landin-Wilhelmsen K; Dahlgren E; Johansson A; Landén M
Psychoneuroendocrinology; 2008 Sep; 33(8):1132-8. PubMed ID: 18672334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
